globenewswire
Grace Therapeutics Announces $10 Million Private Placement
Expected gross proceeds anticipated to extend the Company’s cash runway to the end of calendar 2028PRINCETON, N.J., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. NASDAQ:GRCE (“Grace Therapeutics” or “the Company”), a late-stage, biopharma company advancing GTx-104, a clinical-stage, no…